Clinical trial
Soluble Receptors for Advanced Glycation End-Products to Predict the Type of Stent Implant
NCT01867034 is registered in ClinicalTrials.gov with University of Saskatchewan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Soluble Receptors for Advanced Glycation End-Products to Predict the Type of Stent Implant
- Lead sponsor
- University of Saskatchewan
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- March 31, 2013
- Completion date
- June 30, 2015
- Enrollment
- 30 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.